7GR-35008-49455
3 vaccinations
5 coded responses
13 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Registered in v-safe
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-20
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-07-22
- 2021-10-19
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2021-12-22
Survey response — day 0, dose 3MedDRA: No adverse event — Feeling: Good · Site: PainFree text: None at this time. It has been four hours since booster injection.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenitis — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Inflamed lymph nodes in armpit of injection arm.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Enlarged lymph nodes under both arms; visible under injection arm and painful.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-26
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenitis, Lymphadenopathy — Feeling: Fair · Site: PainFree text: Enlarged lymph nodes under both arms; injection arm the most inflamed and is painful when pressure applied. But not as bad as previous days.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Enlarged lymph nodes but not nearly as large or sensitive as previously mentionedMedDRA releases: 2024-11 · check-in free text available
- 2021-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
Free text
Release 10 — day 0, dose 3
Systemic reaction (other): None at this time. It has been four hours since booster injection.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Inflamed lymph nodes in armpit of injection arm.
Systemic reaction (other): Enlarged lymph nodes under both arms; visible under injection arm and painful.
Systemic reaction (other): Enlarged lymph nodes under both arms; injection arm the most inflamed and is painful when pressure applied. But not as bad as previous days.
Systemic reaction (other): Enlarged lymph nodes but not nearly as large or sensitive as previously mentioned
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenitis | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release